መነሻ › የበሽታ መከላከያ ሥርዓት እና ችግሮች › ማሳቹሴትስ › Boston
በBoston፣ MA ለየበሽታ መከላከያ ሥርዓት እና ችግሮች የሚደረጉ ክሊኒካዊ ጥናቶች
ለየበሽታ መከላከያ ሥርዓት እና ችግሮች የሚደረጉ 10 ጥናቶች በBoston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Massachusetts General Hospital, Boston
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Brigham and Women's Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana-Farber Cancer Institute, Boston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Massachusetts General Hospital, Boston
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Massachusetts General Hospital, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital, Boston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Brigham and Women's Hospital, Boston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana-Farber Cancer Institute, Boston
በሌሎች ከተሞች ለየበሽታ መከላከያ ሥርዓት እና ችግሮች የሚደረጉ ጥናቶች
- Washington, DC13 ጥናቶች
- New York City, NY12 ጥናቶች
- Philadelphia, PA10 ጥናቶች
- Portland, OR9 ጥናቶች
- Atlanta, GA9 ጥናቶች
- Houston, TX9 ጥናቶች
- Cleveland, OH8 ጥናቶች
- Los Angeles, CA8 ጥናቶች
- Chicago, IL8 ጥናቶች
- Milwaukee, WI6 ጥናቶች
- Seattle, WA6 ጥናቶች
- Cedar Rapids, IA6 ጥናቶች
በBoston ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር111 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር90 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)86 ጥናቶች
- የኮሎሬክታል ካንሰር63 ጥናቶች
- Metastatic Cancer63 ጥናቶች
- የሳንባ ካንሰር62 ጥናቶች
- የእንቁላል ካንሰር61 ጥናቶች
- የፕሮስቴት ካንሰር59 ጥናቶች
- ዲፕሬሽን52 ጥናቶች
- የኤንዶሜትሪየም ካንሰር50 ጥናቶች
- የልብ ድካም44 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ44 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።